Annual Incidence of Treatment-Related Acute Myeloid Leukemia Is Increasing

Summary: More people who survive cancer are later developing a rare blood cancer called treatment-related acute myeloid leukemia (tAML). A 30-year study in Japan found that the rate of tAML has almost doubled. This happens because the chemotherapy or radiation used to treat their first cancer can sometimes cause leukemia years later. The most common first cancers linked to this were other blood cancers, breast cancer, colon cancer, and stomach cancer. Researchers noted a big jump in tAML following breast cancer treatments. As more people survive their first cancer, doctors are working to understand and manage these long-term risks.

Source: rssapp-hematologyadvisor-com URL: hematologyadvisor.com/news/annual-incidence-of-treatment-related-acute-myeloid-leukemia-is-increasing/ (opens in new tab)